The survival benefit of adjuvant radiotherapy for pathological T4N2M0 colon cancer in the Modern Chemotherapy Era: evidence from the SEER database 2004

The survival benefit of adjuvant radiotherapy for pathological T4N2M0 colon cancer in the Modern Chemotherapy Era: evidence from the SEER database 2004–2015

Published:2020-01-01 Issue:1 Volume:48 Page:834-840
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Huang Yong¹,Gu Xi²,Ge Kuanxue³,Fu Guangshun¹,Chu Junfeng⁴,Wei Wei¹

Affiliation:

1. Department of General Surgery, Jiangdu People’s Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China

2. Department of General Surgery, Nanjing Jiangbei People’s Hospital, Nanjing, Jiangsu, China

3. Department of Gastroenterology, Jiangdu People’s Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China

4. Department of Radiotherapy, Jiangdu People’s Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2020.1770270

Reference20 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2. Cancer statistics, 2019

3. Management and Outcome After Multivisceral Resections in Patients with Locally Advanced Primary Colon Cancer

4. Adjuvant radiation therapy for T4 non-rectal colon adenocarcinoma provides a cause-specific survival advantage: A SEER database analysis

5. Evolving Treatment Paradigm in the Treatment of Locally Advanced Rectal Cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study protocol of short-course radiotherapy combined with CAPOX and PD-1 inhibitor for locally advanced colon cancer: a randomised, prospective, multicentre, phase II trial (TORCH-C);BMJ Open;2024-02

2. Optimal treatment strategy and prognostic analysis for patients with non-metastatic pT4 colon adenocarcinoma;Frontiers in Oncology;2024-01-08

3. LncRNA HOTAIR promotes DNA damage repair and radioresistance by targeting ATR in colorectal cancer;Oncology Research;2024

4. Preoperative radiotherapy does not improve and may even be detrimental to the long-term prognosis of patients diagnosed with stage III colon adenocarcinoma: a propensity score-matched SEER database analysis;Frontiers in Oncology;2023-11-22

5. Pretreatment Carcinoembryonic Antigen Level Serves as a Potential Biomarker to Guide Adjuvant Radiotherapy in pT4N+ Colon Cancer Patients;Journal of Oncology;2023-02-16